Pano Therapeutics
PrivateCompany Overview
Pano Therapeutics is a preclinical-stage biotechnology company that develops CNS-optimized biguanide small molecule drugs for the treatment of neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pano Therapeutics Comparables
Compare Pano Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Connecta Therapeutics | 79% | |
| Morningside | 79% | |
| Autifony Therapeutics Limited | 77% |
Pano Therapeutics Funding Rounds
Historical fundraising activity
Pano Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baszucki Group | Seed |
| Longevitytech.fund | Seed |
| Western Technology Investment | Seed |
Pano Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pano Therapeutics's valuation, stock price, and market status.
Is Pano Therapeutics a public or private company?
Pano Therapeutics is a private company.
What is the current stock price of Pano Therapeutics?
Pano Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pano Therapeutics worth (valuation)?
Valuation information for Pano Therapeutics is not publicly available.
Can I buy Pano Therapeutics stock?
Pano Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pano Therapeutics's last funding round?
Funding round information for Pano Therapeutics is not publicly available.
Who are the main investors in Pano Therapeutics?
Key investors in Pano Therapeutics include Baszucki Group, Longevitytech.fund, Western Technology Investment.
Will Pano Therapeutics IPO soon?
No public IPO plans have been announced for Pano Therapeutics.
How can I track Pano Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pano Therapeutics's secondary market activity and sign up for updates.